The Influence of 5-HTTLPR, BDNF Rs6265 and COMT Rs4680 Polymorphisms on Impulsivity in Bipolar Disorder: The Role of Gender.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
09 03 2022
Historique:
received: 09 02 2022
revised: 28 02 2022
accepted: 02 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 28 4 2022
Statut: epublish

Résumé

Impulsivity has been proposed as an endophenotype for bipolar disorder (BD); moreover, impulsivity levels have been shown to carry prognostic significance and to be quality-of-life predictors. To date, reports about the genetic determinants of impulsivity in mood disorders are limited, with no studies on BD individuals. Individuals with BD and healthy controls (HC) were recruited in the context of an observational, multisite study (GECOBIP). Subjects were genotyped for three candidate single-nucleotide polymorphisms (SNPs) (5-HTTLPR, COMT rs4680, BDNF rs6265); impulsivity was measured through the Italian version of the Barratt Impulsiveness Scale (BIS-11). A mixed-effects regression model was built, with BIS scores as dependent variables, genotypes of the three polymorphisms as fixed effects, and centers of enrollment as random effect. Compared to HC, scores for all BIS factors were higher among subjects with euthymic BD (adjusted β for Total BIS score: 5.35, p < 0.001). No significant interaction effect was evident between disease status (HC vs. BD) and SNP status for any polymorphism. Considering the whole sample, BDNF Met/Met homozygosis was associated with lower BIS scores across all three factors (adjusted β for Total BIS score: −10.2, p < 0.001). A significant 5-HTTLPR x gender interaction was found for the SS genotype, associated with higher BIS scores in females only (adjusted β for Total BIS score: 12.0, p = 0.001). Finally, COMT polymorphism status was not significantly associated with BIS scores. In conclusion, BD diagnosis did not influence the effect on impulsivity scores for any of the three SNPs considered. Only one SNP—the BDNF rs6265 Met/Met homozygosis—was independently associated with lower impulsivity scores. The 5-HTTLPR SS genotype was associated with higher impulsivity scores in females only. Further studies adopting genome-wide screening in larger samples are needed to define the genetic basis of impulsivity in BD.

Identifiants

pubmed: 35328036
pii: genes13030482
doi: 10.3390/genes13030482
pmc: PMC8954186
pii:
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0
SLC6A4 protein, human 0
Serotonin Plasma Membrane Transport Proteins 0
COMT protein, human EC 2.1.1.6
Catechol O-Methyltransferase EC 2.1.1.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Harv Rev Psychiatry. 2016 Jan-Feb;24(1):36-52
pubmed: 26735322
Addict Biol. 2013 Sep;18(5):836-45
pubmed: 22339949
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):182-91
pubmed: 22735397
Transl Psychiatry. 2014 Sep 30;4:e451
pubmed: 25268255
Psychiatry Res. 2017 Jul;253:211-219
pubmed: 28391138
J Affect Disord. 2012 Feb;136(3):304-9
pubmed: 22154887
BMC Psychiatry. 2017 May 3;17(1):159
pubmed: 28468681
Pers Individ Dif. 2015 Aug 1;82:61-66
pubmed: 25960587
Brain Behav. 2018 Jul;8(7):e01009
pubmed: 29858545
Int J Neuropsychopharmacol. 2018 Jun 1;21(6):528-538
pubmed: 29432620
Science. 1996 Nov 29;274(5292):1527-31
pubmed: 8929413
J Neurosci. 2019 Mar 27;39(13):2562-2572
pubmed: 30718321
Front Hum Neurosci. 2016 Jul 29;10:370
pubmed: 27524961
Neuroscientist. 2019 Oct;25(5):434-454
pubmed: 30387693
Psychiatry Res. 2019 Apr;274:395-399
pubmed: 30852433
Neuroscience. 2006 Apr 28;139(1):201-8
pubmed: 16324792
Alcohol Clin Exp Res. 2009 Apr;33(4):693-702
pubmed: 19170664
Behav Med. 2013;39(2):25-8
pubmed: 23668908
Cephalalgia. 2017 May;37(6):592-598
pubmed: 27154995
J Affect Disord. 2011 Sep;133(1-2):221-6
pubmed: 21550122
Neurosci Lett. 2014 Oct 17;582:16-20
pubmed: 25168604
Front Psychiatry. 2020 Nov 19;11:585852
pubmed: 33329128
World J Biol Psychiatry. 2019 Feb;20(2):137-149
pubmed: 28914102
J Neurochem. 2010 Sep;114(6):1745-55
pubmed: 20626558
J Affect Disord. 2009 Jan;112(1-3):19-29
pubmed: 18455241
Psychiatr Danub. 2018 Mar;30(1):47-56
pubmed: 29546858
J Affect Disord. 2015 Jun 1;178:18-24
pubmed: 25770479
Soc Neurosci. 2019 Apr;14(2):183-190
pubmed: 29210327
World J Psychiatry. 2015 Sep 22;5(3):255-9
pubmed: 26425440
Clin Psychopharmacol Neurosci. 2016 Feb 29;14(1):88-95
pubmed: 26792045
Am J Psychiatry. 2019 May 1;176(5):376-387
pubmed: 30845820
J Affect Disord. 2016 Jul 1;198:88-95
pubmed: 27011364
Cogn Affect Behav Neurosci. 2020 Feb;20(1):59-75
pubmed: 31802408
Psychiatry Res. 2014 Aug 15;218(1-2):236-43
pubmed: 24726025
Neuropsychobiology. 2006;54(1):70-4
pubmed: 17028448
Bipolar Disord. 2012 Aug;14(5):565-70
pubmed: 22805501
Lancet. 2016 Apr 9;387(10027):1561-1572
pubmed: 26388529
Eur Neuropsychopharmacol. 2014 Apr;24(4):510-8
pubmed: 24486183
Neurosci Lett. 2010 Apr 12;473(3):208-11
pubmed: 20188795
Arch Gen Psychiatry. 2011 May;68(5):444-54
pubmed: 21199959
Hum Brain Mapp. 2020 Nov;41(16):4518-4528
pubmed: 32697408
J Affect Disord. 2004 Oct 1;82(1):131-4
pubmed: 15465586
Pharmacogenetics. 1996 Jun;6(3):243-50
pubmed: 8807664
Am J Med Genet B Neuropsychiatr Genet. 2013 Mar;162B(2):137-45
pubmed: 23255304
J Affect Disord. 2011 Aug;132(3):432-7
pubmed: 21492940
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1263-8
pubmed: 18495314
Int J Neuropsychopharmacol. 2014 Jun;17(6):851-8
pubmed: 24438559
Mol Psychiatry. 2018 Jan;23(1):133-142
pubmed: 28373689
Aging Dis. 2018 Jun 1;9(3):523-536
pubmed: 29896439
Aust N Z J Psychiatry. 2018 Sep;52(9):876-886
pubmed: 29969910
Neuropsychopharmacology. 2010 Nov;35(12):2414-26
pubmed: 20736997
J Affect Disord. 2019 Jan 15;243:545-551
pubmed: 30146088
Am J Psychiatry. 2011 Oct;168(10):1041-9
pubmed: 21890791
Nature. 2016 Apr 21;532(7599):334-9
pubmed: 27049939
Br J Nutr. 2017 Oct;118(8):629-637
pubmed: 28969722
Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1742-5
pubmed: 16985039
Front Psychol. 2020 Jan 14;10:2893
pubmed: 31993004
J Affect Disord. 2019 Feb 1;244:33-41
pubmed: 30336349
Neuropsychobiology. 2017;76(4):209-221
pubmed: 30041166
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:214-226
pubmed: 30217771
Neurosci Biobehav Rev. 2012 Oct;36(9):2165-77
pubmed: 22813992
Biol Psychiatry. 2006 Jul 15;60(2):93-105
pubmed: 16406007
J Affect Disord. 2003 Jul;75(2):149-54
pubmed: 12798254
Indian J Psychiatry. 2019 Mar-Apr;61(2):156-160
pubmed: 30992610
Compr Psychiatry. 2017 Jan;72:83-87
pubmed: 27768944
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:185-7
pubmed: 23269345
PLoS One. 2015 Mar 16;10(3):e0119743
pubmed: 25775400
J Psychiatr Res. 2011 Mar;45(3):309-21
pubmed: 20667552
Eat Weight Disord. 2012 Mar;17(1):e62-5
pubmed: 22751274
J Psychiatr Res. 2005 Mar;39(2):179-82
pubmed: 15589566
Genes Brain Behav. 2007 Oct;6(7):647-52
pubmed: 17504250
J Clin Psychol. 2001 Jun;57(6):815-28
pubmed: 11344467
Nat Commun. 2019 Apr 11;10(1):1687
pubmed: 30976000
Diagnostics (Basel). 2020 Jun 20;10(6):
pubmed: 32575733
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124
Brain Res Mol Brain Res. 2005 Oct 31;140(1-2):86-90
pubmed: 16109452
Compr Psychiatry. 2014 Aug;55(6):1337-41
pubmed: 24889339
Int J Eat Disord. 2012 May;45(4):492-500
pubmed: 22271509
Hum Brain Mapp. 2015 Jan;36(1):313-23
pubmed: 25220079
Neuropsychobiology. 2010;61(1):19-26
pubmed: 19923862
PLoS One. 2011 Feb 28;6(2):e16927
pubmed: 21386887
Psychosom Med. 2001 Mar-Apr;63(2):300-5
pubmed: 11292279
Neuroimage. 2015 May 1;111:505-12
pubmed: 25652393
Eur Eat Disord Rev. 2016 Mar;24(2):169-73
pubmed: 26621270
Am J Psychiatry. 2001 Nov;158(11):1783-93
pubmed: 11691682
Am J Psychiatry. 2003 Apr;160(4):636-45
pubmed: 12668349
Clin Psychol Rev. 2011 Nov;31(7):1209-23
pubmed: 21889436
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):111-4
pubmed: 19853632
Suicide Life Threat Behav. 2017 Apr;47(2):177-192
pubmed: 27406282
Neuroimage. 2013 Oct 1;79:264-74
pubmed: 23660028
Compr Psychiatry. 2014 Oct;55(7):1479-84
pubmed: 25035161
PLoS One. 2014 Jan 20;9(1):e85506
pubmed: 24465579
J Affect Disord. 2015 Sep 15;184:51-9
pubmed: 26070046
Psychiatry Res. 2010 Jun 30;178(1):132-6
pubmed: 20434221
Bipolar Disord. 2013 Mar;15(2):223-7
pubmed: 23286455
BMC Public Health. 2014 Jun 03;14:551
pubmed: 24894449
J Affect Disord. 2019 Jan 15;243:552-558
pubmed: 30078664
Psychiatry Clin Neurosci. 2012 Oct;66(6):529-32
pubmed: 22989319
Cell. 2003 Jan 24;112(2):257-69
pubmed: 12553913
Epidemiol Psychiatr Sci. 2019 Oct 25;29:e63
pubmed: 31648654
Am J Psychiatry. 2013 Jan;170(1):23-30
pubmed: 23223834
J Psychiatr Res. 2017 Nov;94:208-217
pubmed: 28756290
Psychiatry Investig. 2013 Sep;10(3):246-52
pubmed: 24302947
Front Genet. 2018 Nov 27;9:583
pubmed: 30542371
Basic Clin Neurosci. 2018 Nov-Dec;9(6):429-438
pubmed: 30719257

Auteurs

Andrea Boscutti (A)

Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.

Alessandro Pigoni (A)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Social and Affective Neuroscience Group, MoMiLab, IMT School for Advanced Studies Lucca, 55100 Lucca, Italy.

Giuseppe Delvecchio (G)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Matteo Lazzaretti (M)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Gian Mario Mandolini (GM)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Paolo Girardi (P)

Department of Developmental Psychology and Socialization, University of Padua, 35131 Padua, Italy.

Adele Ferro (A)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Michela Sala (M)

Mental Health Department, Azienda Sanitaria Locale Alessandria, 15121 Alessandria, Italy.

Vera Abbiati (V)

Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.

Marco Cappucciati (M)

Department of Mental Health and Substance Abuse, Azienda Sanitaria Locale Piacenza, 29121 Piacenza, Italy.

Marcella Bellani (M)

Section of Psychiatry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Cinzia Perlini (C)

Section of Clinical Psychology, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Maria Gloria Rossetti (MG)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Section of Psychiatry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Matteo Balestrieri (M)

Psychiatry Unit, Department of Medicine, University of Udine, 33100 Udine, Italy.

Giuseppe Damante (G)

Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.

Carolina Bonivento (C)

IRCCS "E. Medea", Polo Friuli-Venezia Giulia, San Vito al Tagliamento, 33078 Pordenone, Italy.

Roberta Rossi (R)

Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio FBF, 25125 Brescia, Italy.

Livio Finos (L)

Department of Developmental Psychology and Socialization, University of Padua, 35131 Padua, Italy.

Alessandro Serretti (A)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, 40123 Bologna, Italy.

Paolo Brambilla (P)

Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH